I note Dendreon has 125 mil shares cf Prima @ very roughly 600 mil. This gives a ballpark of US$6 per PRR share if no further dilution.
If the PRR patented process for cancer can be successfully applied to other cancers....well....who knows what value these shares have.
I see the timetable for 'results to market' may be over 2 years. Deals with other parties no doubt would be more fruitful (read valuable) the more 'proven' the treatment.
Therefore PRR seems to be a longer term hold at this stage to realise it's optimum return over a time frame.
Can anyone shed some light on the above points. I realise a lot is guesswork at this stage.
I wouldn't mind some more definitive information on PRR beyond their announcements. Anyone????
I note Dendreon has 125 mil shares cf Prima @ very roughly 600...
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
-0.040(11.9%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 32.0¢ | 33.0¢ | 28.0¢ | $7.278M | 23.75M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 53192 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.5¢ | 41048 | 1 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| IMM (ASX) Chart |